ArticleClinicoEconomics and outcomes research : CEOR2023

Healthcare Resource Utilization and Cost Burden of BCG-Treated Non-Muscle Invasive Bladder Cancer Patients in Germany: A Retrospective Claims Analysis.

Nadia Quignot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.